Astrazeneca ploughs £300m into UK in surprise U-turn Pharma British drugs giant Astrazeneca has promised to plough £300m into its UK operations, just months after cancelling a nine-figure investment in a new lab after getting in a spat with the UK government over drug pricing. In a stunning volte-face, the UK’s largest pharmaceutical company said it would revive its £200m investment into a megalab [...]
High energy prices make the UK ‘vulnerable’ US ambassador warns Business The US ambassador to the UK has warned Britain’s sky-high energy prices threaten to undermine its status as a major global economy. Speaking at an event at the Savoy Hotel on Wednesday, Warren Stephens described UK energy prices, which are among the highest in the world, as the “chief obstacle” to growth. “Energy costs in [...]
Ministers planning drug pricing shake-up to stem pharma exodus pharma Ministers are drawing up a radical overhaul of NHS spending rules in a bid to shore up the UK’s world-leading life sciences industry after a string of pharma giants cancelled major UK investment projects. In what would amount to one of the largest shake-ups of NHS drug purchasing rules in recent history, the Prime Minister [...]
UK drug prices necessary to stop feud with companies, says science minister September 25, 2025 The price the NHS pays for medicines will need to rise to end the feud with pharmaceutical companies and stop the exodus of investment in the UK, science minister Patrick Vallance has said. Lord Vallance told the Financial Times that “all options” were on the table in terms of UK drug pricing, after several large [...]
Why is the pharmaceutical industry turning its back on the UK? September 18, 2025 Since coming into power last year, Rachel Reeves and Keir Starmer have consistently stressed the importance of the life science sector to the UK economy, viewing it as critical for growth. In its aim to boost the industry’s standing, Labour pledged to make the UK an attractive place for investment and innovation, and to increase [...]
Big pharma’s devastating retreat from the UK September 16, 2025 Merck and AstraZeneca’s withdrawal from UK investment is a warning signal to Rachel Reeves – but is she listening? Asks Oliver Dean Both AstraZeneca and Merck’s decision to abandon their respective UK expansions is more than a corporate setback. It is a catastrophic loss of jobs, investment and future innovation and the public are now [...]
Week in Business: Businesses flee high-tax Britain September 11, 2025 On the same day that Reeves said "there's no growth without investment", a pharma giant pulled its £1bn London investment plans.
